Impact of Effective Management Strategies on Patients with the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy

Advances in treatment options for hypertrophic cardiomyopathy (HC) patients have proven effective in many patients for promoting favorable long-term outcomes. Whether this expectation is similar for patients with the most extreme expression of massive LV hypertrophy, a particularly aggressive form of the disease is unresolved. Of 1766 consecutive HC patients presenting to Tufts HC Institute (2004 to 2015), 92 were identified with extreme LV wall thickness (30-48 mm), and compared to 1674 HC patients with less marked hypertrophy (13mm-29 mm).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research